CONSIDERATIONS TO KNOW ABOUT API PHARMACEUTICAL

“The current predicament has uncovered some structural weaknesses within the EU’s medicines source chain and also a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She suggested that supply chain concerns be resolved within an EU pharmaceutical method envisioned for being launched